Dana-Farber Cancer Institute, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America.
Columbia University, New York, New York, United States of America.
PLoS One. 2019 Jun 26;14(6):e0218660. doi: 10.1371/journal.pone.0218660. eCollection 2019.
Castleman disease (CD) describes a spectrum of heterogeneous disorders defined by characteristic lymph node histopathology. Enlarged lymph nodes demonstrating CD histopathology can occur in isolation (unicentric CD; UCD) sometimes accompanied by mild symptoms, or at multiple sites (multicentric CD, MCD) with systemic inflammation and cytokine-driven multi-organ dysfunction. The discovery that Kaposi sarcoma herpesvirus/human herpesvirus (HHV)-8 drives MCD in a subset of patients has led to the hypotheses that UCD and MCD patients with negative HHV-8 testing by conventional methods may represent false negatives, or that these cases are driven by another virus, known or unknown. To investigate these hypotheses, the virome capture sequencing for vertebrate viruses (VirCapSeq-VERT) platform was employed to detect RNA transcripts from known and novel viruses in fresh frozen lymph node tissue from CD patients (12 UCD, 11 HHV-8-negative MCD [idiopathic MCD; iMCD], and two HHV-8-positive MCD) and related diseases (three T cell lymphoma and three Hodgkin lymphoma). This assay detected HHV-8 in both HHV-8-positive cases; however, HHV-8 was not found in clinically HHV-8-negative iMCD or UCD cases. Additionally, no novel viruses were discovered, and no single known virus was detected with apparent association to HHV-8-negative CD cases. Herpesviridae family members, notably including Epstein-Barr virus (EBV), were detected in 7 out of 12 UCD and 5 of 11 iMCD cases with apparent correlations with markers of disease severity in iMCD. Analysis of a separate cohort of archival formalin-fixed, paraffin-embedded lymph node tissue by In situ hybridization revealed significantly fewer EBV-positive cells in UCD and iMCD compared to tissue from HHV-8-positive MCD and EBV-associated lymphoproliferative disorder. In an additional cohort, quantitative testing for EBV by PCR in peripheral blood during disease flare did not detect systemic EBV viremia, suggesting detection lymph node tissue is due to occult, local reactivation in UCD and iMCD. This study confirms that HHV-8 is not present in UCD and iMCD patients. Further, it fails to establish a clear association between any single virus, novel or known, and CD in HHV-8-negative cases. Given that distinct forms of CD exist with viral and non-viral etiological drivers, CD should be considered a group of distinct and separate diseases with heterogeneous causes worthy of further study.
卡斯尔曼病(CD)描述了一组以特征性淋巴结组织病理学为特征的异质性疾病。表现为 CD 组织病理学的增大淋巴结可孤立发生(单中心 CD;UCD),有时伴有轻微症状,或在多个部位发生(多中心 CD,MCD),伴有全身炎症和细胞因子驱动的多器官功能障碍。卡波西肉瘤疱疹病毒/人类疱疹病毒(HHV)-8 驱动 MCD 在一部分患者中的发现导致了以下假设:通过常规方法进行 HHV-8 检测呈阴性的 UCD 和 MCD 患者可能代表假阴性,或者这些病例由另一种病毒驱动,已知或未知。为了研究这些假设,采用脊椎动物病毒的病毒组捕获测序(VirCapSeq-VERT)平台,在来自 CD 患者(12 例 UCD、11 例 HHV-8 阴性 MCD[特发性 MCD;iMCD]和 2 例 HHV-8 阳性 MCD)和相关疾病(3 例 T 细胞淋巴瘤和 3 例霍奇金淋巴瘤)的新鲜冷冻淋巴结组织中检测已知和新型病毒的 RNA 转录本。该检测方法在两种 HHV-8 阳性病例中均检测到 HHV-8;然而,在临床上 HHV-8 阴性的 iMCD 或 UCD 病例中未发现 HHV-8。此外,未发现新的病毒,也未发现任何一种与 HHV-8 阴性 CD 病例明显相关的已知病毒。疱疹病毒科家族成员,特别是 EBV,在 12 例 UCD 中的 7 例和 11 例 iMCD 中的 5 例中被检出,与 iMCD 中的疾病严重程度标志物有明显相关性。通过原位杂交对另一批存档的福尔马林固定、石蜡包埋的淋巴结组织进行分析显示,与 HHV-8 阳性 MCD 和 EBV 相关的淋巴增生性疾病相比,UCD 和 iMCD 中的 EBV 阳性细胞明显减少。在另一个队列中,在疾病发作期间通过 PCR 对外周血中的 EBV 进行定量检测未检测到系统性 EBV 病毒血症,这表明在 UCD 和 iMCD 中,检测到的淋巴结组织是由于隐匿性、局部再激活。这项研究证实 HHV-8 不存在于 UCD 和 iMCD 患者中。此外,它未能在 HHV-8 阴性病例中建立任何单一病毒(新型或已知)与 CD 之间的明确关联。鉴于存在具有病毒和非病毒病因驱动因素的不同形式的 CD,CD 应被视为一组具有不同病因的不同和独立疾病,值得进一步研究。